-
Regulatory November 7, 2025Nomination Committee appointed for the Annual General Meeting 2026 in Vivesto
-
Non Regulatory November 4, 2025Vivesto receives positive new Cantrixil preclinical results in AML
-
Non Regulatory August 14, 2025First patient dosed in Vivesto’s Paccal Vet dose-finding study in cats
Interim Report Q2 2025 (in Swedish)
Vivesto published its Q2 report for 2025 on August 12, 2025, at 08.00 am CEST.